• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3D; ABSORBABLE MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEPHA, INC. - 3005670760 GALAFLEX 3D; ABSORBABLE MESH Back to Search Results
Model Number 100042-03
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Wound Dehiscence (1154)
Date of Event 04/24/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As reported, patient experienced wound dehiscence and treated with wound care post implant of galaflex 3d.Based on the information provided, no conclusions can be made.Wound dehiscence is a known inherent risk of surgery/use of the device and is included as a possible complication in the adverse reaction section of the instructions-for-use (ifu).Review of manufacturing records confirms product was manufactured to specification.This mdr reports the ae of right breast (device #1).An additional mdr was submitted to report the ae of left breast (device #2).Note, the date of event (24-apr2024) is considered to be a best estimate based on the date of awareness.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : not returned - remains implanted.
 
Event or Problem Description
As reported, the patient underwent a bilateral mastopexy with breast implants and a galaflex 3d.It was reported that the patient experienced bilateral incisional wound dehiscence post-operatively.The patient was treated with wound care and the right breast was healed; however, on the left breast side, the wound remains open and did not appear to be incorporating.As reported, surgeon is considering a revision procedure to possibly remove the mesh bilaterally.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAFLEX 3D
Common Device Name
ABSORBABLE MESH
Manufacturer (Section D)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer (Section G)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key19277642
Report Number1213643-2024-00243
Device Sequence Number7592288
Product Code OOD
UDI-Device Identifier00810054980285
UDI-Public(01)00810054980285
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K161092
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 04/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number100042-03
Device Catalogue NumberSH3D03
Device Lot NumberLXHR0032
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/24/2024
Initial Report FDA Received Date05/09/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age46 YR
Patient SexFemale
-
-